Stock Track | AKESO Soars 6.61% Intraday on ASCO Abstract Embargo Lifting and Biotech Sector Strength

Stock Track

May 21

AKESO's stock surged 6.61% during intraday trading on Thursday, marking a significant rebound for the biopharmaceutical company.

The rally was primarily driven by the imminent lifting of the ASCO abstract embargo, which is expected to reveal detailed poster presentations for the company's key products ivonescimab and cadonilimab. These presentations will cover new indication expansion data in head and neck squamous cell carcinoma and metastatic colorectal cancer, with ivonescimab having been selected for an ASCO plenary session oral presentation.

The movement also reflects broad-based strength across the biotech sector and comes after the stock had declined significantly from its April high, representing a cumulative pullback exceeding 26% following earlier clinical trial results.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1112122857"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1112122857\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1112122857?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-21 09:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1112122857","market":"sg","top_or_hot":-1,"title":"Stock Track | AKESO Soars 6.61% Intraday on ASCO Abstract Embargo Lifting and Biotech Sector Strength","media":"Stock Track","content":"<p>AKESO's stock surged 6.61% during intraday trading on Thursday, marking a significant rebound for the biopharmaceutical company.</p><p>The rally was primarily driven by the imminent lifting of the ASCO abstract embargo, which is expected to reveal detailed poster presentations for the company's key products ivonescimab and cadonilimab. These presentations will cover new indication expansion data in head and neck squamous cell carcinoma and metastatic colorectal cancer, with ivonescimab having been selected for an ASCO plenary session oral presentation.</p><p>The movement also reflects broad-based strength across the biotech sector and comes after the stock had declined significantly from its April high, representing a cumulative pullback exceeding 26% following earlier clinical trial results.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | AKESO Soars 6.61% Intraday on ASCO Abstract Embargo Lifting and Biotech Sector Strength</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | AKESO Soars 6.61% Intraday on ASCO Abstract Embargo Lifting and Biotech Sector Strength\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-21 09:51</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>AKESO's stock surged 6.61% during intraday trading on Thursday, marking a significant rebound for the biopharmaceutical company.</p><p>The rally was primarily driven by the imminent lifting of the ASCO abstract embargo, which is expected to reveal detailed poster presentations for the company's key products ivonescimab and cadonilimab. These presentations will cover new indication expansion data in head and neck squamous cell carcinoma and metastatic colorectal cancer, with ivonescimab having been selected for an ASCO plenary session oral presentation.</p><p>The movement also reflects broad-based strength across the biotech sector and comes after the stock had declined significantly from its April high, representing a cumulative pullback exceeding 26% following earlier clinical trial results.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09926","symbol_name":"康方生物","start_time":0,"source_url":"","article_id":"1112122857","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1112122857","pubTimestamp":1779328304,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"AKESO's stock surged 6.61% during intraday trading on Thursday, marking a significant rebound for the biopharmaceutical company.The rally was primarily driven by the imminent lifting of the ASCO...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09926":"康方生物"},"translate_title":"个股追踪|ASCO摘要解禁生物科技板块走强康方生物盘中大涨6.61%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09926":1},"content_text":"AKESO's stock surged 6.61% during intraday trading on Thursday, marking a significant rebound for the biopharmaceutical company.The rally was primarily driven by the imminent lifting of the ASCO abstract embargo, which is expected to reveal detailed poster presentations for the company's key products ivonescimab and cadonilimab. These presentations will cover new indication expansion data in head and neck squamous cell carcinoma and metastatic colorectal cancer, with ivonescimab having been selected for an ASCO plenary session oral presentation.The movement also reflects broad-based strength across the biotech sector and comes after the stock had declined significantly from its April high, representing a cumulative pullback exceeding 26% following earlier clinical trial results.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}